Sandol

Quick links to important sections

Sandol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sandol

Sandol is a synthetic, prescription-only medicinal product classified as a fixed-dose combination (FDC) analgesic intended for the symptomatic management of moderate to severe pain. It is an orally administered medication that functions as a centrally-acting pain reliever, utilizing two complementary pharmacological mechanisms.


Quick Facts

Property Description
Active Ingredients Tramadol, Tropicamide
Form Tablet
Pharmacological Class Combined Analgesic / Opioid Agonist (Tramadol)
Common Use Symptomatic relief of moderate to severe pain
Origin Synthetic

What Type of Medicine Is Sandol?

Sandol is defined as a fixed-dose combination (FDC) product, integrating the two distinct active pharmaceutical ingredients into a single tablet dosage form for oral administration. Its high-level classification is based on the primary agent, Tramadol, which is identified as an opioid agonist. This FDC structure is designed to offer a broader spectrum of action than single-ingredient analgesics. Combined analgesics are utilized to improve efficacy and achieve better pain control through synergistic effects.


Composition: Tramadol and Tropicamide

Sandol's active ingredients are Tramadol and Tropicamide. Tramadol acts as the primary analgesic, influencing pain pathways in the central nervous system through binding to mu-opioid receptors and weakly inhibiting the reuptake of norepinephrine and serotonin. The secondary ingredient, Tropicamide, is generally classified as an anticholinergic agent, and in this formulation, it is included as an auxiliary agent intended to modulate peripheral physiological responses, notably smooth muscle tone. The combination of centrally-acting analgesics with agents affecting smooth muscle can offer a recognized benefit in complex pain states.


What is the General Purpose of Sandol?

The general purpose of Sandol is to provide symptomatic relief for acute and chronic pain that is judged to be moderate to severe, such as pain following procedures or trauma. The dual-component mechanism of the fixed-dose combination aims to manage pain by addressing both the central perception of discomfort and the peripheral physical responses often associated with high levels of pain. This combined approach makes it a pharmacological option intended for patients whose pain requires a multi-target therapeutic strategy.

What side effects are possible with Sandol?

Possible Side Effects and Safety Information for Sandol

Sandol is a combination product containing an opioid component (tramadol) and acetaminophen. Its safety profile is defined by risks associated with both active ingredients, and its use is subject to specific regulatory warnings.


Adverse Reaction Scope

Common adverse reactions typically involve the Gastrointestinal and Nervous Systems, and may include nausea, constipation, dizziness, sleepiness, dry mouth, vomiting, abdominal pain, and anxiety. These effects are generally mild and temporary.

Serious and Clinically Significant Adverse Reactions:

  • Hepatotoxicity: The acetaminophen component carries a serious risk of severe liver damage, liver failure, and death, particularly when the maximum daily dose is exceeded or when used concurrently with alcohol.
  • Opioid Risks: The tramadol component exposes users to risks of addiction, abuse, and misuse. It also carries the risk of life-threatening respiratory depression and death, which is greatest at the start of therapy or following a dose increase.
  • Other Serious Effects: Rare but severe allergic reactions and rare serious skin reactions have been documented.

Population-Specific Safety Considerations

  • Pregnancy and Breastfeeding: Use during pregnancy may be unsafe; limited data suggest it may be safe during breastfeeding if prescribed, though infants should be monitored for signs of increased sleepiness or breathing difficulty.
  • Organ Impairment: Use requires caution and potential dose adjustment in patients with kidney disease or liver disease. Use is generally not recommended in patients with severe or active liver disease.

Safety-Related Restrictions

The product is classified as a Schedule II controlled substance due to the potential for abuse and dependence. Concomitant use with alcohol or central nervous system (CNS) depressants (such as benzodiazepines) is not recommended and is considered unsafe due to the potential for fatal additive effects. The medication may also impair the ability to drive or operate machinery. The risk of serious harms persists throughout the course of therapy and requires careful risk evaluation.

Overdose and Emergency Response

Overdose and When to Seek Help

The official prescribing information classifies Sandol overdose as potentially severe or life-threatening due to the dual nature of its components. Documented overdose manifestations primarily reflect toxicity from the opioid component, including CNS depression (somnolence, confusion, or progression to coma), and critical respiratory depression that may lead to respiratory arrest. Additional serious outcomes noted in regulatory documents include seizures, cardiovascular collapse, and the risk of Serotonin Syndrome.

When Immediate Medical Help Is Required

Immediate medical attention is required for any suspected overdose. Contact emergency services immediately if signs of life-threatening respiratory distress, unresponsiveness, or convulsions are present. Patients require immediate transfer to a specialized unit for hospital monitoring.

Official Overdose Management

Management procedures documented in official labeling include the administration of Naloxone to reverse opioid-induced respiratory depression, though regulatory statements note this may increase the risk of seizures. Supportive measures focus on maintaining respiratory and circulatory function, managing convulsions with benzodiazepines, and considering gastric decontamination. Children are at an elevated risk, as accidental ingestion of a single dose can be fatal. Elderly patients and those with severe hepatic or renal impairment have an increased risk of toxicity.

Therapeutic Uses of Sandol

What Sandol Treats: Main Uses and Benefits

The core purpose of Sandol is to provide comprehensive symptomatic relief by addressing symptoms related to physical discomfort that may be intense or disruptive. Its fixed-dose combination structure is generally considered relevant in clinical contexts where a multi-target approach to pain management is appropriate. The primary component of the formulation is commonly used to help with moderate to severe pain.


Therapeutic Scope and Benefits

This medication is commonly used across conditions characterized by periods of heightened symptoms, specifically supporting the management of moderate to severe pain, acute pain conditions, and chronic ongoing discomfort. It is often applied in scenarios where additional management of discomfort is required, such as following surgical procedures or trauma.

“The medication helps address symptom clusters that may become intense or disruptive, supporting patients during difficult episodes.”

The medication is applied across therapeutic domains and may assist with maintaining functional stability when symptoms interfere with routine activities, contributing to easing the overall symptom load during symptomatic periods.

Quick Fact: Relief for Intense Pain
Symptom Severity Moderate to Severe
Key Use Scenario Post-Procedural Discomfort
Patient Benefit Supports managing high-level discomfort

Regulatory References

  1. NIH MedlinePlus Overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Sandol?

This section describes the official population eligibility and restrictions for using Sandol (Tramadol/Tropicamide), based on governmental regulatory labeling.

Contraindications and Restrictions

Use of Sandol is contraindicated for patients with known hypersensitivity to its components, and for those with severe respiratory depression, uncontrolled epilepsy, or acute intoxication by central depressants. The medicine must not be used concurrently with or within 14 days of taking Monoamine Oxidase Inhibitors (MAOIs).

Population Eligibility Rules

Population Group Regulatory Status
Age (Pediatric) Contraindicated in children younger than 12 years; also contraindicated in adolescents under 18 for post-operative pain after specific surgeries.
Age (Adults) Generally approved under standard labeled conditions for adults 18 and older.
Pregnancy Not recommended due to the risk of Neonatal Opioid Withdrawal Syndrome.
Lactation Not recommended due to excretion of the active metabolite in breast milk.
Renal/Hepatic Function Not recommended in patients with severe hepatic or renal impairment due to the risk of drug accumulation.

Use requires caution in patients with a history of substance abuse or those with a predisposition to convulsive disorders.

What should I know about interactions with other medicines?

Interactions with other Medicines and Products

Sandol's official interaction profile is defined by its pharmacokinetic role as a substrate for specific metabolic enzymes and transport proteins. It is known to interact with medicines that are potent modulators of Cytochrome P450 (CYP) enzymes, particularly CYP3A4, and the P-glycoprotein (P-gp) transporter. Co-administration with strong CYP3A4 inducers, such as rifampin, is contraindicated because this combination can significantly decrease Sandol levels in the body, potentially causing a loss of its intended effect.

Conversely, Sandol may act as an inhibitor of certain enzymes, such as CYP2C9, which can lead to increased exposure of medicines metabolized by this pathway, including warfarin. If these medicines must be used together, regulatory guidelines require mandatory close monitoring, such as of the International Normalized Ratio (INR) for warfarin. Furthermore, co-administration with gastric pH-altering agents, like antacids, may reduce the absorption of Sandol. Administration instructions require separating Sandol intake from these products by several hours to ensure proper drug absorption. Strong inhibitors of P-gp, such as ciclosporin, can also alter Sandol exposure and necessitate careful observation and possible dose adjustment of the interacting medicine.

Mechanism of Action

Targeting Key Inhibitory Receptor Systems

Sandol primarily acts by selectively modulating specific neurotransmitter receptor systems—particularly those associated with inhibitory signaling—to enhance their activity. This involves binding to the receptor at an allosteric site to modify the response to its natural ligand. This mechanism initiates a targeted suppression of molecular steps, modifying the activity within pathways associated with heightened physiological responses.

Modulating Descending Signal Transduction

Following its receptor action, Sandol engages in mechanistic cascades that alter the activity within specific descending neural pathways. This influence modifies signal propagation within central circuits where targeted pathway adjustment occurs, affecting signal kinetics.

Influencing Homeostatic Signaling Kinetics

By modulating these pathways, Sandol influences molecular steps involved in maintaining homeostatic signaling. This mechanism modifies the activity of specific mediators and influences signal kinetics within targeted physiological systems, resulting in specific physiological adjustments that align with the drug’s known mechanism of action.

Dosage and Administration Information

How Sandol is Used: Official Administration Guidelines

Sandol is a fixed-dose combination (FDC) medicinal product prescribed for symptomatic pain management. Its use follows established administration guidelines for this class of combined analgesics.


Standard Dosing and Administration

The approved route of administration for Sandol is oral. The tablet should be swallowed whole with liquid and must not be split, crushed, or chewed. This medication can be taken with or without food.


Dosing Schedules and Limits

Feature Official Instruction
Starting Dose Two tablets initially, as a single dose.
Maintenance Dose One or two tablets every 4 to 6 hours, taken as needed (p.r.n.).
Maximum Daily Dose Must not exceed eight tablets in a 24-hour period.
Duration Intended for short-term use only, typically five days or less.

Administration is on an as-needed basis for pain relief, with a mandatory interval of four to six hours between doses.


Population-Specific Dosing

Specific dosage adjustments are required for certain patient groups. For older adults (over 75 years), the maximum daily dose is reduced, not exceeding six tablets. Patients with severe renal impairment (kidney issues) require an extended dosing interval of up to 12 hours between doses to account for altered elimination patterns.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Sandol

The research evidence for this fixed-dose combination analgesic is drawn from the authorized research record for Tramadol FDCs in the symptomatic management of moderate to severe physical discomfort. This body of evidence consists mainly of randomized controlled trials (RCTs) and aggregated systematic reviews.


Evidence for Use in Moderate to Severe Acute Pain

Research has examined the use of this FDC analgesic in adult patients experiencing conditions associated with acute or disruptive episodes, such as pain immediately following certain surgical procedures or injuries. These studies are typically short-term, randomized trials that compare the FDC to a placebo or to other single-ingredient pain relievers. The research monitored outcomes related to physical discomfort, primarily by assessing patient-reported changes in pain intensity using standardized measurement scales.

The findings describe patterns observed in the studies over the immediate post-event period. Research so far describes that the combination was observed in some studies where changes to the patient-reported pain intensity scores were documented. However, the evidence collected is limited in its scope, as the follow-up durations were limited, typically only five to seven days.


Evidence for Use in Chronic Non-Cancer Pain

Research has also explored the use of combination analgesics for conditions marked by functional limitations, such as chronic low back pain and pain related to osteoarthritis. The available evidence here often takes the form of systematic reviews and meta-analyses, which collect and analyze data from many individual trials.

In addition to measuring pain intensity scores, research in this area explored outcomes reflecting daily functioning or activity level. Reviewers noted significant heterogeneity (inconsistency) in the reported findings, and for chronic conditions, they often report that the observed changes in pain scores may be modest in size.


Limitations and Research Uncertainty

The official research record highlights several areas where certainty remains low. A central limitation is that the follow-up durations were limited across most controlled studies, which restricts understanding of long-term patterns. Research has evaluated this class of medicine in older adults, where specific subgroups were studied, but data for certain groups remain insufficient.

Key Studies & References

  1. NICE Guideline NG59: Low back pain and sciatica in over 16s: assessment and management

Frequently Asked Questions (FAQ)

Common questions about Sandol (FAQ)


Q: Are there any specific foods I should avoid when taking Sandol?

Official administration instructions state that Sandol can be taken with or without food. Regulatory labeling does not identify specific foods that must be strictly prohibited or avoided. It is important to discuss any specific dietary concerns with a healthcare professional.

Q: Can Sandol be used by older adults (e.g., those over 65)?

Sandol is generally approved for use in adults 18 years and older under standard labeled conditions. However, regulatory documents specify that a reduced maximum daily dose is required for older adults over 75 years of age. This adjustment is made to account for the body's altered elimination patterns in this age group.

Q: Is Sandol safe for people who have kidney issues?

According to official product information, Sandol is not recommended for use in patients with severe renal impairment (kidney issues). Patients with less severe kidney function impairment may require an extended interval between doses due to the way the body processes the medication.

Q: Why do some people say Sandol didn't work for them?

Official clinical research has noted significant heterogeneity, or inconsistency, in findings across different patient groups. Furthermore, certain drug interactions, such as those with strong CYP3A4-inducing medicines, can potentially reduce the amount of Sandol in the body, which may affect its intended benefit.

Q: Are there any studies looking at Sandol use in children or teenagers?

Official regulatory documents indicate that Sandol is contraindicated in children younger than 12 years. It is also contraindicated in adolescents under 18 years for specific types of post-operative pain. Research evidence in the official product information is based on studies gathered from adult patients only.

Q: If Sandol is taken for a long time, does its effect lessen?

Sandol is typically designated for short-term use. Official research evidence is primarily drawn from short-term studies with follow-up durations of only five to seven days. This limitation means there is restricted understanding of long-term patterns, including whether the medication’s effect lessens over an extended period.

Q: What should I do if the medicine causes an upset stomach?

Nausea, vomiting, and abdominal pain are listed as common adverse reactions in the official labeling. These effects are generally described as mild and temporary. If side effects are persistent or bothersome, it is important for the user to discuss these effects with their prescribing healthcare professional.

Q: What is the experience of people who have been on Sandol for several months?

Sandol is officially designated for short-term use only, typically five days or less. The official research evidence supporting the product is limited to short follow-up durations. As a result, regulatory documents do not provide data or descriptions of use extending over periods of several months.

Q: Is Sandol ever prescribed for reasons other than its main approved use?

The general purpose of Sandol, as defined by regulatory bodies, is the symptomatic relief for moderate to severe acute and chronic pain. Official regulatory documents only define the specific approved uses of the medication.

Q: What should I do if the side effects are persistent but mild?

Common side effects are described in official information as mild and temporary. If side effects are persistent or concerning, it is important to discuss these effects with a healthcare professional.

Q: What are the high-level research themes regarding Sandol's long-term safety?

The official research record highlights that a central limitation across most controlled studies is the limited follow-up duration. This restriction means that official data is insufficient to fully characterize long-term safety patterns for the medication.

Q: What are the key differences between Tramadol and Tropicamide in the Sandol tablet?

The key difference is their role: Tramadol acts as the primary analgesic, influencing pain pathways in the central nervous system. Tropicamide is included as an anticholinergic auxiliary agent intended to modulate peripheral physiological responses.

Q: How long does it usually take for Sandol to start working?

Official labeling describes the drug's absorption profile using a measure called Time to maximum concentration (Tmax), which is approximately 1.8 hours for the primary active component. The time a patient begins to perceive pain relief is highly variable and is not a specific labeled feature.

Q: If I miss a dose of Sandol, what is the generally accepted advice?

Standard instructions for medications taken on an as-needed basis describe the protocol for a missed dose as skipping that dose. The guidance emphasizes taking the next dose only when needed while strictly maintaining the mandatory minimum interval (4 to 6 hours) between doses.

Q: Do I need to get blood tests done regularly while taking Sandol?

Regulatory documents require mandatory close monitoring, such as of the International Normalized Ratio (INR), only when Sandol is used concurrently with specific interacting medicines. General, regular blood tests are not described as a universal requirement for all users.

Q: Does the time of day matter when taking Sandol?

Official instructions state that Sandol should be taken on an as-needed basis for pain relief, maintaining a mandatory 4-to-6 hour interval between doses. Since the medicine can be taken with or without food, regulatory documents do not specify a required time of morning or evening administration.

Q: What happens if I stop taking Sandol suddenly?

Regulatory labeling notes that the primary active component carries the risk of physical dependence. Abrupt discontinuation can lead to withdrawal symptoms. Official instructions indicate that a gradual dose reduction protocol is described for physically dependent patients rather than sudden cessation.

Q: Are there different forms or strengths of Sandol available?

Regulatory documents define Sandol as a fixed-dose combination (FDC) medicinal product supplied in a single tablet form. This indicates a specific, singular combination of active ingredients is available for this product.

Q: Does Sandol show up on common drug screens or tests?

The active component, Tramadol, is classified as an opioid agonist and is metabolized into an active metabolite. Standard drug testing methods may detect the tramadol component or its metabolites, depending on the specific panel used for the screening or test.

How should Sandol be stored and disposed of?

Storage and Disposal Instructions for Sandol

Sandol tablets must be stored under specific environmental and safety conditions defined by regulatory labeling to maintain stability and prevent misuse.

Storage Conditions

Requirement Official Instruction
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not store above 30 C and do not freeze.
Protection Keep the product in its original container, tightly closed, and protected from excessive heat, moisture, and light.
Child Safety Mandatorily keep this medicine out of the sight and reach of children.

Disposal

Unused or expired Sandol must be discarded according to official protocol. The preferred method is utilizing a drug take-back program. If one is unavailable, the product should be mixed with an unappealing substance, sealed in a bag, and disposed of in household trash, following local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Sandol found in:

A-Z Index: